Diagnosis and Treatment Strategy Optimization of Severe Pneumonia Based on Multi-omics Data Integration

Launched by CAPITAL MEDICAL UNIVERSITY · Feb 24, 2024

Keywords

ClinConnect Summary

This clinical trial is studying severe community-acquired pneumonia, a serious lung infection that can occur in people not currently in the hospital. The goal is to understand the different causes of this pneumonia at a molecular level, which means looking at the tiny building blocks of our body. Researchers want to find out how to better diagnose and treat this condition by using detailed information from various studies. By doing this, they hope to create a more accurate way to identify the best treatments for patients based on their specific type of pneumonia.

To participate in the trial, individuals must be at least 18 years old and have a clinical diagnosis of community-acquired pneumonia. Unfortunately, pregnant women and those with certain immune or blood disorders are not eligible. Participants can expect to contribute to important research that could lead to faster and more effective treatments for severe pneumonia, helping doctors make better decisions for patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age\> 18 years old
• • Clinical diagnosis of community-acquired pneumonia
• Exclusion Criteria:
• • Pregnancy, perinatal and lactating women
• • Combined immunosuppressive diseases: such as HIV, solid organ transplantation, solid organ/hematologic malignant tumor chemotherapy, rheumatic diseases or glomerular diseases need to take hormone/immunosuppressant therapy
• • Combined blood system diseases: such as leukemia reactions, aplastic anemia, neutropenia or deficiency of granulocytes, previous bone marrow/stem cell transplantation